VENTRIPOINT DIAGNOSTICS LTD

Ventripoint Diagnostics partners with UniDoc to launch a remote cardiac screening platform, promising scalable, cloud‑based heart care and potential growth for investors.

Discover how Calgary‑based VentriPoint Diagnostics is revolutionizing heart disease detection with 3‑D imaging tech and AI‑powered models—boosting accuracy and early care.

VentriPoint Diagnostics: Calgary‑based company using 3‑D imaging tech to boost heart disease diagnostics, expanding market reach amid R&D challenges.

VentriPoint Diagnostics: Calgary‑based company using existing imaging tech to create 3‑D heart models, boosting heart disease diagnosis accuracy and treatment planning.

VentriPoint Diagnostics: 3D heart‑disease tech meets a steeply falling stock, negative P/E and market doubts. Can innovation rescue its future?

VentriPoint Diagnostics transforms 2D cardiac scans into 3D models, boosting heart‑disease diagnostics and early treatment while offering investors a growing health‑tech opportunity.

Ventripoint Diagnostics partners with Ollie Hinkle Heart Foundation to bring AI‑powered 3‑D cardiac imaging to underserved pediatric patients, expanding access and accelerating growth.

VentriPoint Diagnostics transforms 2‑D imaging into 3‑D heart models, boosting diagnostic accuracy and surgical precision for heart disease patients. Discover their innovative tech.

VentriPoint Diagnostics raises $61k CAD in shares to pay debenture interest, preserving liquidity while boosting investor confidence and supporting its AI‑cardiac diagnostics growth.

VentriPoint Diagnostics highlights unseen U.S. cardiovascular market shifts, offering investors insight into future growth and strategic opportunities in cardiac tech.